UK Biotech Launched to Target ‘Dark Antigens’ with Cancer Vaccines
The London-based startup Ervaxx has launched with a €15.8M Series A round to develop cancer…
The London-based startup Ervaxx has launched with a €15.8M Series A round to develop cancer…
The UK company Achilles Therapeutics has raised €110M (£100M) to test its personalized cancer cell…
The Nice-based biotech company Yukin Therapeutics is developing drugs that can work together with checkpoint…
Known for curing US President Jimmy Carter’s cancer, Keytruda continues to benefit many other cancer…
The UK grants Immunocore access to a fast-track scheme that will make its immunotherapy IMCgp100…
Immunocore, one of the only three European biotech unicorns, has presented Phase I results for…
Scientists from the University of Zurich have identified an epigenetic control switch responsible for turning…
eTheRNA has started a Phase Ib trial in patients with melanoma to test a cancer immunotherapy…
This week we had the chance to visit both Grenoble and Liège, where the French-Belgian…
BerGenBio has started a new Phase I/II trial evaluating the addition of its Axl inhibitor…
Amcure and TILT Biotherapeutics announced yesterday new financing rounds supporting the development of unique strategies…
Europe's best companies using bioinformatics to tackle cancer will take part in a huge collaboration…